 Hyperandrogenism
"Hyperandrogenism" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A condition caused by the excessive secretion of ANDROGENS from the ADRENAL CORTEX; the OVARIES; or the TESTES. The clinical significance in males is negligible. In women, the common manifestations are HIRSUTISM and VIRILISM as seen in patients with POLYCYSTIC OVARY SYNDROME and ADRENOCORTICAL HYPERFUNCTION.
| Descriptor ID |
D017588
|
| MeSH Number(s) |
C12.706.316.064.500 C12.706.316.129.750 C13.351.875.253.064.500 C13.351.875.253.129.750 C16.131.939.316.064.500 C16.131.939.316.129.750 C19.391.119.064.500 C19.391.119.129.750
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Hyperandrogenism".
Below are MeSH descriptors whose meaning is more specific than "Hyperandrogenism".
This graph shows the total number of publications written about "Hyperandrogenism" by people in this website by year, and whether "Hyperandrogenism" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2008 | 1 | 0 | 1 | | 2011 | 1 | 0 | 1 | | 2012 | 2 | 0 | 2 | | 2014 | 1 | 0 | 1 | | 2015 | 1 | 0 | 1 | | 2017 | 0 | 1 | 1 | | 2019 | 1 | 0 | 1 | | 2021 | 2 | 0 | 2 |
To return to the timeline, click here.
Below are the most recent publications written about "Hyperandrogenism" by people in Profiles.
-
Wierman ME. Hyperandrogenic Anovulation: Differential Diagnosis and Evaluation. Endocrinol Metab Clin North Am. 2021 03; 50(1):1-10.
-
Zaman A, Rothman MS. Postmenopausal Hyperandrogenism: Evaluation and Treatment Strategies. Endocrinol Metab Clin North Am. 2021 03; 50(1):97-111.
-
Ravi SJ, Cree-Green M. Use of Successive Pharmacologic Hormone Suppression Testing for a Severe Presentation of Adolescent Polycystic Ovarian Syndrome: A Case Report. J Investig Med High Impact Case Rep. 2019 Jan-Dec; 7:2324709619850215.
-
Engmann L, Jin S, Sun F, Legro RS, Polotsky AJ, Hansen KR, Coutifaris C, Diamond MP, Eisenberg E, Zhang H, Santoro N. Racial and ethnic differences in the polycystic ovary syndrome metabolic phenotype. Am J Obstet Gynecol. 2017 05; 216(5):493.e1-493.e13.
-
Cree-Green M, Newcomer BR, Coe G, Newnes L, Baumgartner A, Brown MS, Pyle L, Reusch JE, Nadeau KJ. Peripheral insulin resistance in obese girls with hyperandrogenism is related to oxidative phosphorylation and elevated serum free fatty acids. Am J Physiol Endocrinol Metab. 2015 May 01; 308(9):E726-33.
-
Carreau AM, Baillargeon JP. PCOS in adolescence and type 2 diabetes. Curr Diab Rep. 2015 Jan; 15(1):564.
-
Polotsky AJ, Allshouse AA, Crawford SL, Harlow SD, Khalil N, Kazlauskaite R, Santoro N, Legro RS. Hyperandrogenic oligomenorrhea and metabolic risks across menopausal transition. J Clin Endocrinol Metab. 2014 Jun; 99(6):2120-7.
-
Barthelmess EK, Naz RK. Polycystic ovary syndrome: current status and future perspective. Front Biosci (Elite Ed). 2014 01 01; 6(1):104-19.
-
Sun M, Maliqueo M, Benrick A, Johansson J, Shao R, Hou L, Jansson T, Wu X, Stener-Victorin E. Maternal androgen excess reduces placental and fetal weights, increases placental steroidogenesis, and leads to long-term health effects in their female offspring. Am J Physiol Endocrinol Metab. 2012 Dec 01; 303(11):E1373-85.
-
Polotsky AJ, Allshouse A, Crawford SL, Harlow SD, Khalil N, Santoro N, Legro RS. Relative contributions of oligomenorrhea and hyperandrogenemia to the risk of metabolic syndrome in midlife women. J Clin Endocrinol Metab. 2012 Jun; 97(6):E868-77.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|